RAP is finally gaining traction in the acute respiratory diagnosis for ResAppDx and a well established pharmacy with link to big pharmacy Johnson & Johnson are doing a paid pilot for use of ResAppDx in chronic respiratory management......I honestly don't think you have ever been a holder.
Ann: Trading Halt, page-164
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)